Assyro AI

Orange Book product · Brand (NDA)

EPIDUO

ADAPALENE; BENZOYL PEROXIDE

Brand (NDA)NDA 022320TE ABRX GALDERMA LABS LP

At a glance

Dec 08, 2008

Approved

Brand (NDA)

Application

AB

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 08, 2008

    17 yr 9 mo ago

  2. Today

  3. Patent 8071644 expires

    Listed drug product patent expiration.

    Jul 18, 2027

    in 1 yr 1 mo

  4. Patent 8080537 expires

    Listed method-of-use patent (U-1078) expiration.

    Jul 18, 2027

    in 1 yr 1 mo

  5. Patent 8129362 expires

    Listed method-of-use patent (U-1078) expiration.

    Jul 18, 2027

    in 1 yr 1 mo

Pharmaceutical detail

Active ingredient

ADAPALENE; BENZOYL PEROXIDE

Strength

0.1%;2.5%

Dosage form

GEL

Route

TOPICAL

TE code

AB

Application

NDA 022320

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8071644Jul 18, 2027in 1 yr 1 mo
ProductU-1078
8080537Jul 18, 2027in 1 yr 1 mo
U-1078
8129362Jul 18, 2027in 1 yr 1 mo
U-1078
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.